229 related articles for article (PubMed ID: 11522664)
1. Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool.
Serreze DV; Johnson EA; Chapman HD; Graser RT; Marron MP; DiLorenzo TP; Silveira P; Yoshimura Y; Nathenson SG; Joyce S
Diabetes; 2001 Sep; 50(9):1992-2000. PubMed ID: 11522664
[TBL] [Abstract][Full Text] [Related]
2. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
Kanagawa O; Shimizu J; Vaupel BA
J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
[TBL] [Abstract][Full Text] [Related]
3. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.
Verdaguer J; Schmidt D; Amrani A; Anderson B; Averill N; Santamaria P
J Exp Med; 1997 Nov; 186(10):1663-76. PubMed ID: 9362527
[TBL] [Abstract][Full Text] [Related]
6. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice.
Serreze DV; Choisy-Rossi CM; Grier AE; Holl TM; Chapman HD; Gahagan JR; Osborne MA; Zhang W; King BL; Brown A; Roopenian D; Marron MP
J Immunol; 2008 Mar; 180(5):3250-9. PubMed ID: 18292549
[TBL] [Abstract][Full Text] [Related]
7. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
8. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent.
Shameli A; Clemente-Casares X; Wang J; Santamaria P
J Immunol; 2011 Sep; 187(6):2859-66. PubMed ID: 21824864
[TBL] [Abstract][Full Text] [Related]
9. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
10. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
[TBL] [Abstract][Full Text] [Related]
11. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
Verdaguer J; Yoon JW; Anderson B; Averill N; Utsugi T; Park BJ; Santamaria P
J Immunol; 1996 Nov; 157(10):4726-35. PubMed ID: 8906855
[TBL] [Abstract][Full Text] [Related]
13. A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreas.
Dai YD; Jensen KP; Lehuen A; Masteller EL; Bluestone JA; Wilson DB; Sercarz EE
J Immunol; 2005 Sep; 175(6):3621-7. PubMed ID: 16148106
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a preferential V beta usage by the T cells which adoptively transfer diabetes in NOD mice.
Edouard P; Thivolet C; Bedossa P; Olivi M; Legrand B; Bendelac A; Bach JF; Carnaud C
Eur J Immunol; 1993 Mar; 23(3):727-33. PubMed ID: 8095459
[TBL] [Abstract][Full Text] [Related]
15. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
16. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience.
Choisy-Rossi CM; Holl TM; Pierce MA; Chapman HD; Serreze DV
J Immunol; 2004 Sep; 173(6):3791-800. PubMed ID: 15356126
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
18. CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.
Forsberg MH; Ciecko AE; Bednar KJ; Itoh A; Kachapati K; Ridgway WM; Chen YG
J Immunol; 2017 May; 198(10):3857-3868. PubMed ID: 28363905
[TBL] [Abstract][Full Text] [Related]
19. Protection from type 1 diabetes in the face of high levels of activated autoaggressive lymphocytes in a viral transgenic mouse model crossed to the SV129 strain.
von Herrath MG; Wolfe T; Möhrle U; Coon B; Hughes A
Diabetes; 2001 Dec; 50(12):2700-8. PubMed ID: 11723052
[TBL] [Abstract][Full Text] [Related]
20. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.
Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
